The NPPA has revised prices for 137 non-scheduled anti-cancer drugs after capping trade margins at 30 per cent. Effective November 9, the measure is expected to reduce prices by up to 70 per cent and ease treatment costs.
Cancer drug prices in India could fall under a new Trade Margin Rationalisation (TMR) mechanism covering 137 anti-cancer medicines from November 9. Learn how the 30% trade margin cap, GST reduction and Pharma Sahi Daam app could help patients and families manage cancer treatment costs.
